NCT04543994: An ongoing trial by The Cleveland Clinic
This trial is ongoing. It must report results 6 months, 1 week from now.
Full data
| Full entry on ClinicalTrials.gov | NCT04543994 |
|---|---|
| Title | A Phase IB/IIA Study of Remestemcel-L, an ex Vivo Culture-expanded Adult Allogeneic Bone Marrow Derived Mesenchymal Stem Cell Product, for the Treatment of Medically Refractory Ulcerative Colitis |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Nov. 10, 2020 |
| Completion date | Nov. 30, 2023 |
| Required reporting date | Nov. 29, 2024, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Feb. 9, 2024 |
| Days late | None |